Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis-Reference-Cited by-同舟云学术

Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis

Published:2016-05-27 Issue:5 Volume:214 Page:685-688
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Laprise Jean-François,Markowitz Lauri E.,Chesson Harrell W.,Drolet Mélanie,Brisson Marc

Funder

CDC

Canada Research Chairs program

Canadian Institutes of Health Research

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/214/5/685/17412197/jiw227.pdf

Reference15 articles.

1. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

2. Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women

3. Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study

4. World Health Organization (WHO). Evidence based recommendations on human papilloma virus (HPV) vaccines schedules: background paper for SAGE discussions. http://www.who.int/immunization/sage/meetings/2014/april/1_HPV_Evidence_based_recommendationsWHO_with_Appendices2_3.pdf . Accessed 23 July 2014.

5. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis;BMC Medicine;2023-08-28

2. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella;PharmacoEconomics;2023-02-21

3. Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019–2020;Vaccines;2022-04-08

4. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis;The Lancet Infectious Diseases;2021-11

5. Median Age at HPV Infection Among Women in the United States: A Model-Based Analysis Informed by Real-world Data;Open Forum Infectious Diseases;2021-03-12